Psychoanalyst attitudes towards psychedelic-assisted therapy

Abstract

Background

Numerous clinical trials have supported psychedelic-assisted therapy (PAT) as a treatment for psychiatric disorders such as depression, anxiety, post-traumatic stress, and substance use. While empirical evidence indicates PAT’s benefits, the perspectives of mental health practitioners on this topic remain unclear.

Methods

This quantitative study attempted to capture psychoanalyst practitioners’ attitudes toward PAT. A sample of 130 graduate-level trained psychoanalysts in at least part-time clinical practice was recruited to participate in an online survey.

Results

The study found that psychoanalysts were cautiously supportive of PAT, open to their clients engaging in PAT, and optimistic about PAT’s potential in treating mental disorders. Additionally, they reported that PAT would be ineffective in treating substance use disorders (SUDs). Lastly, participants who reported a history of psychedelic use were significantly more likely to have greater positive attitudes toward PAT than those who had not.

Conclusion

Results indicate the potential for misinformation about psychedelics and a lingering cultural stigma regarding the utility of psychedelics in the therapeutic environment among psychoanalysts. Therefore, education on the risks, potential benefits, and limitations of the evidence base of psychedelics and their effectiveness across psychiatric disorders appears warranted in the psychoanalytic community.

Keywords:

• Psychedelic-assisted therapy
• psychedelics
• psychoanalysts

Disclosure statement

No potential conflict of interest was reported by the author(s).

Additional information

Funding

The author(s) reported there is no funding associated with the work featured in this article.